The article considers a clinical case of a young patient with autoimmune polyglandular
syndrome type 2, represented by type 1 diabetes mellitus, thyroid dysfunction and
primary adrenal cortex insufficiency.
Betterle C., Zanchetta R. Update on autoimmune polyendocrine syndromes (APS).
Clinical Immunology and Allergology. Acta Bio Medica 2003; 74: 1: 9-33.
Kahaly G.J. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009; 161: 1: 11-
doi: 10.1530/eje-09-0044.
Endocrinology. National leadership. Edited By I. I. Dedov, G. A. Melnichenko. M:
GEOTAR-Media, 2008.
Yu. I. Klyuchagina1, Z. A. Sokolova2, M. A. Baryshnikov2. The role of the PD-1 receptor
and its PDL1 and PDL2 ligands in tumor immunotherapy. Oncopediatrics. 2017, 4 (1) 49-
pages.
L. Tsarev , A.V. Melerzanov, Review of approaches to immunotherapy in Oncology.
Journal of Research and practice in medicine 2017, vol. 4, no. 3, pp. 51-65 REVIEW DOI: